US 8703192
Dosage form containing pantoprazole as active ingredient
granted A61KA61K31/44A61K31/4439
Quick answer
US patent 8703192 (Dosage form containing pantoprazole as active ingredient) held by TAKEDA GMBH expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TAKEDA GMBH
- Grant date
- Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/44, A61K31/4439, A61K9/2081, A61K9/2886